Published in Lab Business Week, January 8th, 2006
On the occasion of a private placement, institutional investors as well as existing investors subscribed 2,396,438 shares at the price of EUR4.24 per share. The company's share capital thus increases by 2,396,438 to 10,530,077 shares. The additional capital is to be used chiefly for clinical studies and for further extension of the product pipeline.
On November 25, 4SC AG has filed for listing under the regulated market at the Frankfurt Stock Exchange together with admission to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week